Literature DB >> 6790086

Effects of sodium valproate in 100 children with special reference to weight.

J Egger, E M Brett.   

Abstract

Excessive weight gain occurred in a patient who was taking sodium valproate and phenytoin. The sodium valproate was therefore withdrawn but the rapid weight loss that ensued led to phenytoin intoxication. Hence a retrospective analysis was conducted of 100 children with epilepsy treated with sodium valproate. Fit control improved in 77 and was best in children with generalised epilepsy. None of the reported severe side effects, such as acute liver disease and pancreatitis, were encountered. Milder but troublesome side effects, however, occurred in 65 patients. The commonest was increased weight gain, which occurred in 44 cases. Others were transient gastrointestinal disturbances (20), lassitude (nine), transient hair loss (six), transient enuresis (seven), and aggressive behaviour (four).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6790086      PMCID: PMC1506957          DOI: 10.1136/bmj.283.6291.577

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  18 in total

1.  Na+,K+-ATPase enzyme units in skeletal muscle from lean and obese mice.

Authors:  M H Lin; D R Romsos; T Akera; G A Leveille
Journal:  Biochem Biophys Res Commun       Date:  1978-01-30       Impact factor: 3.575

2.  Sodium valproate increases potassium conductance in Aplysia neurons.

Authors:  G E Slater; D Johnston
Journal:  Epilepsia       Date:  1978-08       Impact factor: 5.864

3.  Valproate, hyperammonaemia, and hyperglycinaemia.

Authors:  J Jaeken; P Casaer; L Corbeel
Journal:  Lancet       Date:  1980-08-02       Impact factor: 79.321

4.  Pancreatitis associated with valproic acid therapy for epilepsy.

Authors:  D L Coulter; R J Allen
Journal:  Ann Neurol       Date:  1980-01       Impact factor: 10.422

5.  Metabolic obesity?

Authors:  P K Bondy
Journal:  N Engl J Med       Date:  1980-10-30       Impact factor: 91.245

Review 6.  Valproic acid. Review of a new antiepileptic drug.

Authors:  J Bruni; B J Wilder
Journal:  Arch Neurol       Date:  1979-07

7.  Reduced activity of the red-cell sodium-potassium pump in human obesity.

Authors:  M De Luise; G L Blackburn; J S Flier
Journal:  N Engl J Med       Date:  1980-10-30       Impact factor: 91.245

8.  Treatment of childhood epilepsy with valproic acid: results of the first 100 patients in a 6-month trial.

Authors:  E S Sherard; G S Steiman; D Couri
Journal:  Neurology       Date:  1980-01       Impact factor: 9.910

9.  Sodium valproate: pharmacokinetics and effectivensss in treating intractable seizures.

Authors:  J E Redenbaugh; S Sato; J K Penry; F E Dreifuss; H J Kupferberg
Journal:  Neurology       Date:  1980-01       Impact factor: 9.910

10.  Treatment of generalized epilepsies of childhood and adolescence with sodium valproate ("epilim").

Authors:  P M Jeavons; J E Clark; M C Maheshwari
Journal:  Dev Med Child Neurol       Date:  1977-02       Impact factor: 5.449

View more
  22 in total

1.  Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months.

Authors:  Tracy A Glauser; Avital Cnaan; Shlomo Shinnar; Deborah G Hirtz; Dennis Dlugos; David Masur; Peggy O Clark; Peter C Adamson
Journal:  Epilepsia       Date:  2012-11-21       Impact factor: 5.864

Review 2.  Risk-benefit assessment of anticonvulsants in women of child-bearing potential.

Authors:  P G Cleland
Journal:  Drug Saf       Date:  1991 Jan-Feb       Impact factor: 5.606

Review 3.  Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy.

Authors:  Jouko I T Isojärvi; Erik Taubøll; Andrew G Herzog
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 4.  Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures: an individual participant data review.

Authors:  Sarah J Nolan; Anthony G Marson; Jennifer Weston; Catrin Tudur Smith
Journal:  Cochrane Database Syst Rev       Date:  2016-04-28

5.  [Pharmacotherapy of cancer pain. 3. Adjuvant drugs.].

Authors:  N I Cherny; R K Portenoy; M Raber; M Zenz
Journal:  Schmerz       Date:  1995-03       Impact factor: 1.107

6.  Obesity is a common comorbidity for pediatric patients with untreated, newly diagnosed epilepsy.

Authors:  Z S Daniels; T G Nick; C Liu; A Cassedy; T A Glauser
Journal:  Neurology       Date:  2009-05-27       Impact factor: 9.910

Review 7.  Concentration-effect relationships of valproic acid.

Authors:  D W Chadwick
Journal:  Clin Pharmacokinet       Date:  1985 Mar-Apr       Impact factor: 6.447

Review 8.  Effect of antiepileptic drugs on bodyweight: overview and clinical implications for the treatment of epilepsy.

Authors:  Victor Biton
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 9.  Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review.

Authors:  Martin J Brodie; Frank Besag; Alan B Ettinger; Marco Mula; Gabriella Gobbi; Stefano Comai; Albert P Aldenkamp; Bernhard J Steinhoff
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

10.  Studies on 2-n-propyl-2(E)-pentenoate (delta 2(E)-valproate) in man.

Authors:  L Gram
Journal:  Pharm Weekbl Sci       Date:  1992-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.